Phase Ib trial of the oral angiogenesis
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib
✍
Grace K. Dy, Jeffrey R. Infante, S. Gail Eckhardt, Silvia Novello, Wen Wee Ma, S
📂
Article
📅
2012
🏛
Springer US
🌐
English
⚖ 238 KB